PAOLO ANDERLINI to Risk Assessment
This is a "connection" page, showing publications PAOLO ANDERLINI has written about Risk Assessment.
Connection Strength
0.022
-
Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development. Bone Marrow Transplant. 2002 Nov; 30(10):661-3.
Score: 0.022